(NASDAQ: CELZ) Creative Medical Technology Holdings's forecast annual revenue growth rate of 1,561.7% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.52%.
Creative Medical Technology Holdings's revenue in 2024 is $9,000.On average, 1 Wall Street analysts forecast CELZ's revenue for 2025 to be $949,638, with the lowest CELZ revenue forecast at $949,638, and the highest CELZ revenue forecast at $949,638. On average, 1 Wall Street analysts forecast CELZ's revenue for 2026 to be $32,436,928, with the lowest CELZ revenue forecast at $32,436,928, and the highest CELZ revenue forecast at $32,436,928.
In 2027, CELZ is forecast to generate $54,441,401 in revenue, with the lowest revenue forecast at $54,441,401 and the highest revenue forecast at $54,441,401.